Technologie de la santé
Sociétés Suisses développant des technologies de santé
Le développement de dispositifs médicaux, de plateformes de diagnostic et de logiciels de santé définit le secteur des technologies de santé. Les délais d’approbation réglementaire et les modèles de remboursement Medicare en évolution injectent constamment de la liquidité dans ces actions. Actuellement, Novartis AG domine le volume d'échanges, tandis que Inovio Pharmaceuticals, Inc. affiche la meilleure performance sur 24 heures. Le tableau ci-dessous organise des données techniques et fondamentales essentielles.
Symbole | Capitalisation boursière | Prix | Chg % | Vol | Vol Rel | P/E | BPA dil TTM | Croissance dil du BPA YoY TTM | Rendement du Dividende % TTM | Note des analystes |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1,09 T CHF | 1 180 CHF | +23,56% | 1 | 0,31 | 46,38 | 25,44 CHF | +57,99% | 0,47% | Strong Buy |
| LLYEli Lilly and Company | 1,09 T CHF | 1 104,870 CHF | −5,56% | 6 | 0,13 | 43,42 | 25,44 CHF | +57,99% | 0,47% | Strong Buy |
 JNJJohnson & Johnson | 543,72 B CHF | 227,679 CHF | +3,11% | 12 | 0,87 | 41,32 | 5,51 CHF | −33,23% | 1,91% | Buy |
| JNJ.USDJohnson & Johnson | 543,72 B CHF | 261,25 USD | 0,00% | 177 | 0,35 | 39,63 | 5,51 CHF | −36,38% | 1,91% | Buy |
 ABBVAbbVie, Inc. | 425,98 B CHF | 236,65 CHF | +1,24% | 20 | 0,30 | 48,72 | 4,86 CHF | +360,13% | 2,35% | Buy |
| 4ABAbbVie, Inc. | 425,98 B CHF | 240,889 CHF | +13,10% | 1,35 K | 9,21 | 49,60 | 4,86 CHF | +360,13% | 2,35% | Buy |
 RHORoche Holding Ltd | 315,59 B CHF | 405,099 CHF | −0,76% | 15 | 0,73 | 26,43 | 15,33 CHF | +30,49% | 2,69% | Buy |
| ROPRoche Holding Ltd | 315,59 B CHF | 386,324 CHF | −1,65% | 344 | 0,41 | 25,21 | 15,33 CHF | +30,49% | 2,48% | Buy |
| RORoche Holding Ltd | 315,59 B CHF | 400,0 CHF | +0,25% | 64,81 K | 2,40 | 26,10 | 15,33 CHF | +30,49% | 2,69% | Buy |
| ROPRoche Holding Ltd | 315,59 B CHF | 390,3 CHF | −0,36% | 1,44 M | 1,30 | 25,47 | 15,33 CHF | +30,49% | 2,48% | Buy |
 6MKMerck & Co., Inc. | 303,22 B CHF | 123,142 CHF | +4,32% | 16 | 0,65 | 150,44 | 0,82 CHF | −86,41% | 2,26% | Buy |
| MRK.USDMerck & Co., Inc. | 303,22 B CHF | 151,22 USD | 0,00% | 1,24 K | 0,89 | 154,43 | 0,82 CHF | −87,05% | 2,26% | Buy |
 NOTNovartis AG | 245,77 B CHF | 132,760 CHF | −1,75% | 127 | 0,24 | 32,00 | 4,15 CHF | −33,04% | 2,76% | Neutre |
| NOVNNovartis AG | 245,77 B CHF | 133,08 CHF | −0,78% | 4,01 M | 1,00 | 32,07 | 4,15 CHF | −33,04% | 2,76% | Neutre |
| NOVNEENovartis AG TEMP | 245,77 B CHF | 132,56 CHF | −1,88% | 130 K | 0,45 | 31,95 | 4,15 CHF | −33,04% | 2,76% | Pas de notation |
 ZEGAstraZeneca PLC | 239,39 B CHF | 155,416 CHF | +1,57% | 211 | 9,91 | 26,62 | 5,84 CHF | +18,22% | 1,70% | Buy |
 TN8Thermo Fisher Scientific Inc. | 213,87 B CHF | 546,250 CHF | −2,06% | 2 | 0,65 | 34,48 | 15,84 CHF | +14,93% | 0,26% | Buy |
 AMGAmgen Inc. | 211,44 B CHF | 388,337 CHF | +1,70% | 9 | 0,76 | 26,94 | 14,41 CHF | +39,89% | 2,08% | Neutre |
 GISGilead Sciences, Inc. | 176,9 B CHF | 134,099 CHF | −5,57% | 20 | 0,15 | — | −2,63 CHF | −151,18% | 1,86% | Buy |
 ABLAbbott Laboratories | 163,38 B CHF | 94,775 CHF | +6,44% | 631 | 30,05 | 41,86 | 2,26 CHF | −64,34% | 2,18% | Buy |
 NVONovo Nordisk A/S Sponsored ADR Class BDR | 154,8 B CHF | 33,873 CHF | +4,89% | 30 | 0,03 | 10,21 | 3,32 CHF | +21,39% | 2,92% | Neutre |
| NOVNovo Nordisk A/S Class B | 154,8 B CHF | 33,068 CHF | +0,66% | 248 | 0,14 | 10,27 | 3,22 CHF | +10,70% | 4,10% | Neutre |
 PFEPfizer Inc. | 143,45 B CHF | 23,577 CHF | −5,69% | 4,31 K | 10,28 | 40,34 | 0,58 CHF | −57,23% | 5,59% | Neutre |
 IUI1Intuitive Surgical, Inc. | 136,6 B CHF | 375,728 CHF | −4,11% | 25 | 1,59 | 54,38 | 6,91 CHF | +14,81% | 0,00% | Buy |
 DAPDanaher Corporation | 135,1 B CHF | 187,464 CHF | −1,94% | 1,65 K | 44,59 | 36,72 | 5,11 CHF | +31,91% | 0,65% | Buy |
 VX1Vertex Pharmaceuticals Incorporated | 113,78 B CHF | 439,008 CHF | −2,56% | 10 | 0,30 | 33,78 | 12,99 CHF | +14,99% | 0,00% | Buy |
 2M6Medtronic Plc | 109,74 B CHF | 85,457 CHF | −0,24% | 4 | 0,15 | 26,04 | 3,28 CHF | +11,14% | 2,72% | Buy |
 BRMBristol-Myers Squibb Company | 107,25 B CHF | 51,175 CHF | +1,34% | 10 | 0,03 | 13,57 | 3,77 CHF | +59,93% | 3,93% | Buy |
 SYKStryker Corporation | 105,69 B CHF | 257,002 CHF | +2,09% | 7 | 0,13 | 32,75 | 7,85 CHF | +29,36% | 1,04% | Buy |
 SANSanofi SA | 92,58 B CHF | 67,98 CHF | 0,00% | 450 | 0,13 | 22,12 | 3,07 CHF | −36,38% | 4,90% | Buy |
| SNWSanofi SA | 92,58 B CHF | 77,442 CHF | +6,14% | 495 | 2,82 | 25,20 | 3,07 CHF | −36,38% | 4,90% | Buy |
 0QFModerna, Inc. | 84,32 B CHF | 214,368 CHF | +8,91% | 2,19 K | 10,49 | — | −6,45 CHF | −8,21% | 0,00% | Neutre |
| MRNAModerna, Inc. | 84,32 B CHF | 161,56 CHF | −20,41% | 8 | — | — | −6,45 CHF | −8,21% | 0,00% | Neutre |
| MRNA.USDModerna, Inc. | 84,32 B CHF | 226,80 USD | 0,00% | 1,93 K | 1,55 | — | −6,45 CHF | −6,20% | 0,00% | Neutre |
 GS71GSK plc | 83,39 B CHF | 20,522 CHF | +1,52% | 3 | 0,04 | 17,34 | 1,18 CHF | −17,14% | 3,60% | Neutre |
 EL1EssilorLuxottica SA | 80,36 B CHF | 179,30 CHF | 0,00% | 1,73 K | 1,57 | 36,29 | 4,94 CHF | +2,56% | 2,12% | Buy |
| ESLEssilorLuxottica SA | 80,36 B CHF | 175,776 CHF | +9,63% | 100 | 1,13 | 35,58 | 4,94 CHF | +2,56% | 2,12% | Buy |
 MRKMerck KGaA | 60,03 B CHF | 138,411 CHF | +6,22% | 200 | 1,68 | 27,50 | 5,03 CHF | −18,23% | 1,46% | Buy |
 BSXBoston Scientific Corporation | 54,29 B CHF | 37,640 CHF | −0,39% | 500 | 2,74 | 19,06 | 1,97 CHF | +32,59% | 0,00% | Buy |
 CSJCSL Limited | 54,2 B CHF | 113,768 CHF | −1,02% | 386 | 1,17 | — | −4,25 CHF | −186,00% | 2,05% | Buy |
 UNCUCB S.A. | 49,28 B CHF | 254,278 CHF | +5,56% | 30 | 1,03 | 24,36 | 10,44 CHF | +62,96% | 0,36% | Buy |
 BAYNBayer AG | 48,9 B CHF | 50,052 CHF | −2,26% | 480 | 0,51 | — | −1,63 CHF | +49,77% | 0,20% | Buy |
| BAYNBayer AG | 48,9 B CHF | 43,46 CHF | 0,00% | 600 | 0,69 | — | −1,63 CHF | +49,77% | 0,20% | Buy |
 SHLSiemens Healthineers AG | 45,93 B CHF | 41,12 CHF | +11,14% | 25 | 0,02 | 22,56 | 1,82 CHF | +1,10% | 2,23% | Buy |
| SHLSiemens Healthineers AG | 45,93 B CHF | 40,107 CHF | −2,47% | 4 | 0,06 | 22,01 | 1,82 CHF | +1,10% | 2,23% | Buy |
 GALDGalderma Group AG | 45,37 B CHF | 189,334 CHF | −3,60% | 213 | 0,88 | 65,20 | 2,90 CHF | +110,71% | 0,18% | Buy |
| GALDGalderma Group AG | 45,37 B CHF | 191,75 CHF | −1,74% | 580,42 K | 1,03 | 66,03 | 2,90 CHF | +110,71% | 0,18% | Buy |
 LONNLonza Group AG | 45,09 B CHF | 663,4 CHF | −1,34% | 212,06 K | 1,42 | — | −1,55 CHF | −115,18% | 0,76% | Buy |
| LO3Lonza Group AG | 45,09 B CHF | 658,428 CHF | −2,15% | 34 | 0,12 | — | −1,55 CHF | −115,18% | 0,76% | Buy |
 IX1IDEXX Laboratories, Inc. | 44,99 B CHF | 561,726 CHF | +28,10% | 100 | 4,37 | 45,29 | 12,40 CHF | +23,43% | 0,00% | Buy |
 D8YSandoz Group Ltd | 36,14 B CHF | 83,263 CHF | +0,29% | 1,07 K | 1,70 | 70,72 | 1,18 CHF | +166,48% | 0,97% | Neutre |
| SDZSandoz Group Ltd | 36,14 B CHF | 83,78 CHF | +0,19% | 893 K | 0,61 | 71,16 | 1,18 CHF | +166,48% | 0,97% | Neutre |
 RVMDRevolution Medicines, Inc. | 34,99 B CHF | 150,462 CHF | −4,57% | 59 | 0,85 | — | −7,13 CHF | −99,36% | 0,00% | Strong Buy |
 2U3Alcon AG | 31,62 B CHF | 60,879 CHF | −3,84% | 1,21 K | 1,58 | 58,72 | 1,04 CHF | −44,92% | 0,44% | Buy |
| ALCAlcon AG | 31,62 B CHF | 61,30 CHF | −2,36% | 1,23 M | 1,27 | 59,12 | 1,04 CHF | −44,92% | 0,44% | Buy |
 ZOEZoetis, Inc. Class A | 30,13 B CHF | 65,569 CHF | +0,36% | 10 | 0,21 | 13,34 | 4,91 CHF | +6,56% | 2,38% | Neutre |
 DC4DexCom, Inc. | 26,97 B CHF | 64,471 CHF | −10,31% | 936 | 7,81 | 30,23 | 2,13 CHF | +49,03% | 0,00% | Strong Buy |
 IM8NInsmed Incorporated | 19,73 B CHF | 91,668 CHF | −4,48% | 48 | — | — | −2,35 CHF | +52,19% | 0,00% | Strong Buy |
 22UABioNTech SE Sponsored ADRDR | 18,62 B CHF | 70,648 CHF | −5,05% | 33 | 0,78 | — | −6,34 CHF | −399,64% | 0,00% | Buy |
 VTRSViatris, Inc. | 18,04 B CHF | 15,755 CHF | +4,80% | 74 | 1,31 | — | −0,29 CHF | +87,49% | 2,50% | Buy |
 DULAlnylam Pharmaceuticals, Inc | 17,64 B CHF | 138,579 CHF | −27,27% | 100 | 1,99 | 8,37 | 16,55 CHF | +8 543,33% | 0,00% | Buy |
 ZBHZimmer Biomet Holdings, Inc. | 17,17 B CHF | 76,0 CHF | +1,33% | 34 | 0,40 | 23,03 | 3,30 CHF | +2,53% | 0,87% | Neutre |
 STMNStraumann Holding AG | 17,12 B CHF | 104,50 CHF | −1,28% | 363,31 K | 0,79 | 45,17 | 2,31 CHF | −5,94% | 0,93% | Buy |
| QS51Straumann Holding AG | 17,12 B CHF | 106,125 CHF | −0,81% | 103 | 0,69 | 45,87 | 2,31 CHF | −5,94% | 0,93% | Buy |
 SOONSonova Holding AG | 16,68 B CHF | 288,0 CHF | −1,44% | 197,29 K | 1,42 | 39,88 | 7,22 CHF | −20,12% | 1,62% | Neutre |
| PHBNSonova Holding AG | 16,68 B CHF | 287,176 CHF | −1,86% | 128 | 0,34 | 39,77 | 7,22 CHF | −20,12% | 1,62% | Neutre |
 EX9Exelixis, Inc. | 14,51 B CHF | 53,452 CHF | +0,45% | 400 | 1,21 | 19,14 | 2,79 CHF | +47,64% | 0,00% | Buy |
 CBHDColoplast A/S Class B | 14,4 B CHF | 59,193 CHF | +1,18% | 2 K | 11,23 | 34,34 | 1,72 CHF | −14,44% | 4,40% | Neutre |
 WDH1Demant A/S | 9,42 B CHF | 45,623 CHF | +35,57% | 7 K | 40,70 | 48,03 | 0,95 CHF | −29,67% | 0,00% | Buy |
 QGENQIAGEN NV | 8,58 B CHF | 41,772 CHF | +40,91% | 10 | 0,10 | 26,25 | 1,59 CHF | +11,53% | 0,69% | Neutre |
 YDO1Madrigal Pharmaceuticals, Inc. | 7,6 B CHF | 358,641 CHF | −0,42% | 12 | 0,38 | — | −5,00 CHF | +51,78% | 0,00% | Strong Buy |
 HDP1Arrowhead Pharmaceuticals, Inc. | 7,12 B CHF | 50,112 CHF | −7,82% | 2 K | 17,39 | — | −1,81 CHF | −80,90% | 0,00% | Strong Buy |
 BANBBachem Holding AG Class B | 6,12 B CHF | 78,273 CHF | −3,74% | 12 | 0,15 | 39,38 | 1,99 CHF | +11,05% | 1,10% | Buy |
| BANBBachem Holding AG Class B | 6,12 B CHF | 79,70 CHF | −0,06% | 58,18 K | 0,78 | 40,10 | 1,99 CHF | +11,05% | 1,10% | Buy |
 YPSNYpsomed Holding AG | 5,28 B CHF | 394,4 CHF | −0,05% | 8,88 K | 0,79 | 24,20 | 16,30 CHF | +154,29% | 1,10% | Buy |
| OWXYpsomed Holding AG | 5,28 B CHF | 387,308 CHF | −4,22% | 1 | 0,04 | 23,76 | 16,30 CHF | +154,29% | 1,10% | Buy |
 1CGCRISPR Therapeutics AG | 4,11 B CHF | 40,056 CHF | −2,75% | 600 | 1,15 | — | −3,97 CHF | +10,71% | 0,00% | Buy |
 SFZNSiegfried Holding AG | 3,38 B CHF | 72,00 CHF | −1,37% | 104,69 K | 0,94 | 18,41 | 3,91 CHF | +11,09% | 0,53% | Buy |
| SFZNSiegfried Holding AG | 3,38 B CHF | 71,467 CHF | −3,66% | 32 | 0,16 | 18,28 | 3,91 CHF | +11,09% | 0,53% | Buy |
 IOVAIovance Biotherapeutics Inc | 3,22 B CHF | 7,100 CHF | −40,91% | 300 | — | — | −0,58 CHF | +40,09% | 0,00% | Buy |
 FIEFielmann Group AG | 3,19 B CHF | 36,668 CHF | +1,13% | 1 K | 6,49 | 15,75 | 2,33 CHF | +23,36% | 3,38% | Buy |
 TECNTecan Group AG | 3,14 B CHF | 257,6 CHF | −1,68% | 75,47 K | 0,91 | — | −9,16 CHF | −284,91% | 1,23% | Buy |
| TENTecan Group AG | 3,14 B CHF | 253,933 CHF | −4,60% | 56 | 1,10 | — | −9,16 CHF | −284,91% | 1,23% | Buy |
 AFXCarl Zeiss Meditec AG | 2,94 B CHF | 32,719 CHF | +1,21% | 100 | 0,21 | 32,70 | 1,00 CHF | −41,01% | 1,54% | Sell |
 MOVEMedacta Group SA | 2,48 B CHF | 106,4 CHF | −13,64% | 142,07 K | 4,92 | 29,74 | 3,58 CHF | −20,27% | 0,89% | Buy |
| 6MDMedacta Group SA | 2,48 B CHF | 106,788 CHF | −10,36% | 170 | 1,81 | 29,85 | 3,58 CHF | −20,27% | 0,89% | Buy |
 EZP1COMET Holding AG | 2,48 B CHF | 304,344 CHF | +2,26% | 4 | 0,08 | 132,65 | 2,29 CHF | −54,20% | 0,16% | Strong Buy |
| COTNCOMET Holding AG | 2,48 B CHF | 298,0 CHF | −0,13% | 57,39 K | 1,51 | 129,88 | 2,29 CHF | −54,20% | 0,16% | Strong Buy |
 RXRXRecursion Pharmaceuticals, Inc. Class A | 1,98 B CHF | 3,117 CHF | −4,45% | 4 K | 5,28 | — | −0,75 CHF | +48,25% | 0,00% | Buy |
 METNMetall Zug AG Class B | 1,8 B CHF | 835 CHF | 0,00% | 228 | 2,26 | — | −12,44 CHF | +56,17% | 0,00% | Neutre |
| NDH1Metall Zug AG Class B | 1,8 B CHF | 820,202 CHF | −0,27% | 2 | 0,21 | — | −12,44 CHF | +56,17% | 0,00% | Neutre |
 7VGSKAN Group AG | 1,61 B CHF | 73,514 CHF | +1,51% | 41 | 0,40 | 55,12 | 1,33 CHF | +85,35% | 0,31% | Strong Buy |
| SKANSKAN Group AG | 1,61 B CHF | 69,7 CHF | −0,99% | 33,43 K | 0,94 | 52,26 | 1,33 CHF | +85,35% | 0,31% | Strong Buy |
 MEDMedartis Holding AG | 1,51 B CHF | 109,6 CHF | +2,05% | 14,27 K | 0,78 | 91,44 | 1,20 CHF | — | 0,00% | Strong Buy |
 NVV1Novavax, Inc. | 1,44 B CHF | 8,008 CHF | −3,65% | 500 | 1,61 | — | −1,23 CHF | −168,74% | 0,00% | Buy |
 8H0PolyPeptide Group AG | 1,36 B CHF | 43,866 CHF | −0,37% | 400 | 0,36 | 108,53 | 0,40 CHF | — | 0,00% | Neutre |
| PPPGNEPolyPeptide Group AG TEMP | 1,36 B CHF | 44,00 CHF | +0,34% | 1,97 K | 0,19 | 108,86 | 0,40 CHF | — | 0,00% | Pas de notation |
| PPGNPolyPeptide Group AG | 1,36 B CHF | 40,05 CHF | −1,11% | 21,45 K | 0,97 | 99,08 | 0,40 CHF | — | 0,00% | Neutre |
 19TIdorsia Ltd. | 1,19 B CHF | 4,023 CHF | −8,69% | 100 | 0,08 | — | −1,11 CHF | −66,32% | 0,00% | Neutre |
| IDIAIdorsia Ltd. | 1,19 B CHF | 4,058 CHF | −3,38% | 997,2 K | 1,24 | — | −1,11 CHF | −66,32% | 0,00% | Neutre |